Abstracts of the 10th Central European Lung Cancer Conference, June 18-21, 2006, Prague, Czech RepublicZATLOUKAL, Petr; PETRUZELKA, Luboš.Lung cancer. 2006, Vol 52, issn 0169-5002, 52 p., SUP2Conference Proceedings

Czech study on lung cancer screening : Post-trial follow-up of lung cancer deaths up to Year 15 since enrollmentKUBIK, Antonin K; PARKIN, D. Maxwell; ZATLOUKAL, Petr et al.Cancer. 2000, Vol 89, Num 11, pp 2363-2368, issn 0008-543X, SUPConference Paper

Lung cancer in womenPAUK, Norbert; KUBIK, Antonin; ZATLOUKAL, Petr et al.Lung cancer. 2005, Vol 48, Num 1, pp 1-9, issn 0169-5002, 9 p.Article

Adenocarcinoma of the lung among women: risk associated with smoking, prior lung disease, diet and menstrual and pregnancy historyZATLOUKAL, Petr; KUBIK, Antonin; PAUK, Norbert et al.Lung cancer. 2003, Vol 41, Num 3, pp 283-293, issn 0169-5002, 11 p.Article

Expression of apoptosome pathway-related transcripts in non-small cell lung cancerKREPELA, Evzen; PROCHAZKA, Jan; FIALA, Pavel et al.Journal of cancer research and clinical oncology. 2006, Vol 132, Num 1, pp 57-68, issn 0171-5216, 12 p.Article

Gefitinib Versus Vinorelbine in Chemotherapy-Naive Elderly Patients With Advanced Non-Small-Cell Lung Cancer (INVITE) : A Randomized, Phase II StudyCRINO, Lucio; CAPPUZZO, Federico; DUFFIELD, Emma L et al.Journal of clinical oncology. 2008, Vol 26, Num 26, pp 4253-4260, issn 0732-183X, 8 p.Article

Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized studyZATLOUKAL, Petr; PETRUZELKA, Lubos; ZEMANOVA, Milada et al.Lung cancer. 2004, Vol 46, Num 1, pp 87-98, issn 0169-5002, 12 p.Article

Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non-Small-Cell Lung Cancer : AVAiLRECK, Martin; VON PAWEL, Joachim; MANEGOLD, Christian et al.Journal of clinical oncology. 2009, Vol 27, Num 8, pp 1227-1234, issn 0732-183X, 8 p.Article

Randomized Phase III Trial Comparing Bexarotene (L1069-49)/Cisplatin/Vinorelbine With Cisplatin/Vinorelbine in Chemotherapy-Naive Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer : SPIRIT IRAMLAU, Rodryg; ZATLOUKAL, Petr; ZHANG, Joseph K et al.Journal of clinical oncology. 2008, Vol 26, Num 11, pp 1886-1892, issn 0732-183X, 7 p.Article

Phase iii study of adjuvant vaccination with Bec2/bacille calmette-guerin in responding patients with limited-disease small-cell lung cancer (european organisation for research and treatment of cancer 08971-08971B; Silva study)GIACCONE, Giuseppe; DEBRUYNE, Channa; ZATLOUKAL, Petr et al.Journal of clinical oncology. 2005, Vol 23, Num 28, pp 6854-6864, issn 0732-183X, 11 p.Article

A phase I pharmacokinetic study of bexarotene with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)WAKELEE, Heather A; MIDDLETON, Gary; DUNLOP, David et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 3, pp 815-824, issn 0344-5704, 10 p.Article

The effect of bexarotene on atorvastatin pharmacokinetics: results from a phase I trial of bexarotene plus chemotherapy in patients with advanced non-small cell lung cancerWAKELEE, Heather A; TAKIMOTO, Chris H; ZATLOUKAL, Petr et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 2, pp 563-571, issn 0344-5704, 9 p.Article

A case-control study of lung cancer among Czech womenKUBIK, Antonin; ZATLOUKAL, Petr; BOYLE, Peter et al.Lung cancer. 2001, Vol 31, Num 2-3, pp 111-122, issn 0169-5002Article

Phase III Trial Comparing Vinflunine With Docetaxel in Second-Line Advanced Non-Small-Cell Lung Cancer Previously Treated With Platinum-Containing ChemotherapyKRZAKOWSKI, Maciej; RAMLAU, Rodryg; DELGADO, François M et al.Journal of clinical oncology. 2010, Vol 28, Num 13, pp 2167-2173, issn 0732-183X, 7 p.Article

Multicenter Phase II Trial ofYM155, a Small-Molecule Suppressor of Survivin, in Patients With Advanced, Refractory, Non―Small-Cell Lung CancerGIACCONE, Giuseppe; ZATLOUKAL, Petr; ROUBEC, Jaromir et al.Journal of clinical oncology. 2009, Vol 27, Num 27, pp 4481-4486, issn 0732-183X, 6 p.Article

Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trialZATLOUKAL, Petr; PETRUZELKA, Lubos; HORENKOVA, Eva et al.Lung cancer. 2003, Vol 41, Num 3, pp 321-331, issn 0169-5002, 11 p.Article

Randomized phase II study of carboplatin and etoposide with or without obatoclax mesylate in extensive-stage small cell lung cancerLANGER, Corey J; ALBERT, Istvan; SCHREEDER, Marshall T et al.Lung cancer. 2014, Vol 85, Num 3, pp 420-428, issn 0169-5002, 9 p.Article

Randomized Phase II Study of Dulanermin in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Advanced Non-Small-Cell Lung CancerSORIA, Jean-Charles; MARK, Zsuzsanna; HEI, Yong-Jiang et al.Journal of clinical oncology. 2011, Vol 29, Num 33, pp 4442-4451, issn 0732-183X, 10 p.Article

Increased expression of inhibitor of apoptosis proteins, survivin and XIAP, in non-small cell lung carcinomaKREPELA, Evzen; DANKOVA, Petra; MORAVCIKOVA, Erika et al.International journal of oncology. 2009, Vol 35, Num 6, pp 1449-1462, issn 1019-6439, 14 p.Article

Safety and Efficacy of Darbepoetin Alfa in Previously Untreated Extensive-Stage Small-Cell Lung Cancer Treated With Platinum Plus EtoposidePIRKER, Robert; RAMLAU, Rodryg A; SCHUETTE, Wolfgang et al.Journal of clinical oncology. 2008, Vol 26, Num 14, pp 2342-2349, issn 0732-183X, 8 p.Article

Symptom and quality of life results of an international randomised phase III study of adjuvant vaccination with Bec2/BCG in responding patients with limited disease small-cell lung cancerBOTTOMLEY, Andrew; DEBRUYNE, Channa; FELIP, Enriqueta et al.European journal of cancer (1990). 2008, Vol 44, Num 15, pp 2178-2184, issn 0959-8049, 7 p.Article

Cisplatin-versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer : An individual patient data meta-analysisARDIZZONI, Andrea; BONI, Luca; BISSET, Donald et al.Journal of the National Cancer Institute. 2007, Vol 99, Num 11, pp 847-857, issn 0027-8874, 11 p.Article